CT of heart transplant recipients: Spectrum of disease

Friedrich D Knollmann, Manfred Hummel, Roland Hetzer, Roland Felix

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The emergence of heart transplantation as the ultimate treatment for end-stage heart failure has been accompanied by new diagnostic challenges. Computed tomography (CT) has emerged as an important diagnostic tool in the evaluation of heart transplant recipients because many infectious, ischemic-hemorrhagic, and neoplastic complications are amenable to early detection with this modality. In the early postoperative period, CT is mostly indicated in the evaluation of infectious complications or cerebral symptoms. Later, CT is mostly performed for staging of infectious or neoplastic disease. Infectious complications include mediastinitis, soft-tissue inflammation, abscess formation, cerebral infarction, and aspergillosis. Complications related to ischemia or hemorrhage include allograft rejection and coronary allograft vasculopathy, the latter being the leading long-term cause of death in heart transplant recipients. CT is also indicated in malignant disease (eg, lymphoma, visceral carcinoma, skin tumors), which is the second most important long-term cause of death. Moreover, CT is helpful in identifying disease caused by immunosuppressive therapy (eg, leukoencephalopathy, osteoporosis, thoracic lipomatosis). CT has proved superior to both ultrasound and magnetic resonance imaging in the evaluation of heart transplant recipients. It has become the diagnostic modality of choice for many transplant-related complications and may help improve postoperative treatment of affected patients.

Original languageEnglish (US)
Pages (from-to)1637-1648
Number of pages12
JournalRadiographics
Volume20
Issue number6
StatePublished - Nov 2000
Externally publishedYes

Fingerprint

Tomography
Allografts
Cause of Death
Lipomatosis
Mediastinitis
Leukoencephalopathies
Aspergillosis
Cerebral Infarction
Heart Transplantation
Immunosuppressive Agents
Postoperative Period
Abscess
Osteoporosis
Transplant Recipients
Lymphoma
Thorax
Therapeutics
Ischemia
Heart Failure
Magnetic Resonance Imaging

Keywords

  • Aspergillosis, 60.2056
  • Brain, diseases, 10.8722
  • Coronary vessels, diseases, 54.459, 54.754
  • Grafts, 51.459, 54.459
  • Heart, transplantation, 51.459
  • Lipoma and lipomatosis, 60.319
  • Lymphoma, 34
  • Osteoporosis, 30.56, 40.56

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Knollmann, F. D., Hummel, M., Hetzer, R., & Felix, R. (2000). CT of heart transplant recipients: Spectrum of disease. Radiographics, 20(6), 1637-1648.

CT of heart transplant recipients : Spectrum of disease. / Knollmann, Friedrich D; Hummel, Manfred; Hetzer, Roland; Felix, Roland.

In: Radiographics, Vol. 20, No. 6, 11.2000, p. 1637-1648.

Research output: Contribution to journalArticle

Knollmann, FD, Hummel, M, Hetzer, R & Felix, R 2000, 'CT of heart transplant recipients: Spectrum of disease', Radiographics, vol. 20, no. 6, pp. 1637-1648.
Knollmann FD, Hummel M, Hetzer R, Felix R. CT of heart transplant recipients: Spectrum of disease. Radiographics. 2000 Nov;20(6):1637-1648.
Knollmann, Friedrich D ; Hummel, Manfred ; Hetzer, Roland ; Felix, Roland. / CT of heart transplant recipients : Spectrum of disease. In: Radiographics. 2000 ; Vol. 20, No. 6. pp. 1637-1648.
@article{166b0feadd234678afc69a6a4e728f9c,
title = "CT of heart transplant recipients: Spectrum of disease",
abstract = "The emergence of heart transplantation as the ultimate treatment for end-stage heart failure has been accompanied by new diagnostic challenges. Computed tomography (CT) has emerged as an important diagnostic tool in the evaluation of heart transplant recipients because many infectious, ischemic-hemorrhagic, and neoplastic complications are amenable to early detection with this modality. In the early postoperative period, CT is mostly indicated in the evaluation of infectious complications or cerebral symptoms. Later, CT is mostly performed for staging of infectious or neoplastic disease. Infectious complications include mediastinitis, soft-tissue inflammation, abscess formation, cerebral infarction, and aspergillosis. Complications related to ischemia or hemorrhage include allograft rejection and coronary allograft vasculopathy, the latter being the leading long-term cause of death in heart transplant recipients. CT is also indicated in malignant disease (eg, lymphoma, visceral carcinoma, skin tumors), which is the second most important long-term cause of death. Moreover, CT is helpful in identifying disease caused by immunosuppressive therapy (eg, leukoencephalopathy, osteoporosis, thoracic lipomatosis). CT has proved superior to both ultrasound and magnetic resonance imaging in the evaluation of heart transplant recipients. It has become the diagnostic modality of choice for many transplant-related complications and may help improve postoperative treatment of affected patients.",
keywords = "Aspergillosis, 60.2056, Brain, diseases, 10.8722, Coronary vessels, diseases, 54.459, 54.754, Grafts, 51.459, 54.459, Heart, transplantation, 51.459, Lipoma and lipomatosis, 60.319, Lymphoma, 34, Osteoporosis, 30.56, 40.56",
author = "Knollmann, {Friedrich D} and Manfred Hummel and Roland Hetzer and Roland Felix",
year = "2000",
month = "11",
language = "English (US)",
volume = "20",
pages = "1637--1648",
journal = "Radiographics",
issn = "0271-5333",
publisher = "Radiological Society of North America Inc.",
number = "6",

}

TY - JOUR

T1 - CT of heart transplant recipients

T2 - Spectrum of disease

AU - Knollmann, Friedrich D

AU - Hummel, Manfred

AU - Hetzer, Roland

AU - Felix, Roland

PY - 2000/11

Y1 - 2000/11

N2 - The emergence of heart transplantation as the ultimate treatment for end-stage heart failure has been accompanied by new diagnostic challenges. Computed tomography (CT) has emerged as an important diagnostic tool in the evaluation of heart transplant recipients because many infectious, ischemic-hemorrhagic, and neoplastic complications are amenable to early detection with this modality. In the early postoperative period, CT is mostly indicated in the evaluation of infectious complications or cerebral symptoms. Later, CT is mostly performed for staging of infectious or neoplastic disease. Infectious complications include mediastinitis, soft-tissue inflammation, abscess formation, cerebral infarction, and aspergillosis. Complications related to ischemia or hemorrhage include allograft rejection and coronary allograft vasculopathy, the latter being the leading long-term cause of death in heart transplant recipients. CT is also indicated in malignant disease (eg, lymphoma, visceral carcinoma, skin tumors), which is the second most important long-term cause of death. Moreover, CT is helpful in identifying disease caused by immunosuppressive therapy (eg, leukoencephalopathy, osteoporosis, thoracic lipomatosis). CT has proved superior to both ultrasound and magnetic resonance imaging in the evaluation of heart transplant recipients. It has become the diagnostic modality of choice for many transplant-related complications and may help improve postoperative treatment of affected patients.

AB - The emergence of heart transplantation as the ultimate treatment for end-stage heart failure has been accompanied by new diagnostic challenges. Computed tomography (CT) has emerged as an important diagnostic tool in the evaluation of heart transplant recipients because many infectious, ischemic-hemorrhagic, and neoplastic complications are amenable to early detection with this modality. In the early postoperative period, CT is mostly indicated in the evaluation of infectious complications or cerebral symptoms. Later, CT is mostly performed for staging of infectious or neoplastic disease. Infectious complications include mediastinitis, soft-tissue inflammation, abscess formation, cerebral infarction, and aspergillosis. Complications related to ischemia or hemorrhage include allograft rejection and coronary allograft vasculopathy, the latter being the leading long-term cause of death in heart transplant recipients. CT is also indicated in malignant disease (eg, lymphoma, visceral carcinoma, skin tumors), which is the second most important long-term cause of death. Moreover, CT is helpful in identifying disease caused by immunosuppressive therapy (eg, leukoencephalopathy, osteoporosis, thoracic lipomatosis). CT has proved superior to both ultrasound and magnetic resonance imaging in the evaluation of heart transplant recipients. It has become the diagnostic modality of choice for many transplant-related complications and may help improve postoperative treatment of affected patients.

KW - Aspergillosis, 60.2056

KW - Brain, diseases, 10.8722

KW - Coronary vessels, diseases, 54.459, 54.754

KW - Grafts, 51.459, 54.459

KW - Heart, transplantation, 51.459

KW - Lipoma and lipomatosis, 60.319

KW - Lymphoma, 34

KW - Osteoporosis, 30.56, 40.56

UR - http://www.scopus.com/inward/record.url?scp=0034329968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034329968&partnerID=8YFLogxK

M3 - Article

C2 - 11112818

AN - SCOPUS:0034329968

VL - 20

SP - 1637

EP - 1648

JO - Radiographics

JF - Radiographics

SN - 0271-5333

IS - 6

ER -